Clinical trials
Central Serous Chorioretinopathy clinical trials
Below are recruiting central serous chorioretinopathy clinical trials, each written for real people, not researchers. We’re tracking 5 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05570591Recruiting
Laser treatment for long-lasting central serous eye fluid
This trial tests a low-energy “subthreshold” laser to treat long-lasting fluid under the retina from central serous chorioretinopathy (CSCR). It may help dry up the fluid and improve vision, compared with a sham (placebo) treatment.
East Melbourne, VictoriaAges 18–70 - NCT05589974Recruiting
Blood flow study in acute or chronic central serous eye disease
This study measures blood flow in the eye in people with acute or chronic central serous chorioretinopathy (CSC). It uses eye scans and special imaging to better understand what’s happening and whether it may differ between short-term and long-term disease.
StavangerAges 18–70 - NCT06346405Recruiting
Laser treatment for chronic central serous chorioretinopathy
This study tests a gentle laser treatment called micropulse laser for people with chronic central serous chorioretinopathy. It aims to help dry up the fluid under the retina that has not responded to standard medications for at least 6 months.
Roma, RAges 18–70 - NCT06527326Recruiting
Gut bacteria and central serous chorioretinopathy study
This study looks at the link between gut bacteria and central serous chorioretinopathy (CSC), a condition where fluid builds up under the retina. It may help us understand why some people get CSC and find better ways to treat it.
Hanzhou, ZhejiangAges Any age - NCT02141308Recruiting
OCT eye imaging for rare retinal and choroid diseases
This trial studies rare diseases affecting the retina or choroid using detailed eye scans (OCT). It may help doctors better understand how these conditions look in the eye and how imaging findings relate to vision.
Portland, OregonAges 7–100
Hear when a new Central Serous Chorioretinopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for central serous chorioretinopathy?
- Yes. Clin2 currently lists 5 recruiting central serous chorioretinopathy studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a central serous chorioretinopathy trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a central serous chorioretinopathy trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.